Marloes Stam

1.6k total citations
25 papers, 851 citations indexed

About

Marloes Stam is a scholar working on Genetics, Surgery and Molecular Biology. According to data from OpenAlex, Marloes Stam has authored 25 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 13 papers in Surgery and 11 papers in Molecular Biology. Recurrent topics in Marloes Stam's work include Neurogenetic and Muscular Disorders Research (23 papers), RNA modifications and cancer (10 papers) and Congenital Anomalies and Fetal Surgery (10 papers). Marloes Stam is often cited by papers focused on Neurogenetic and Muscular Disorders Research (23 papers), RNA modifications and cancer (10 papers) and Congenital Anomalies and Fetal Surgery (10 papers). Marloes Stam collaborates with scholars based in Netherlands, Germany and United States. Marloes Stam's co-authors include W. Ludo van der Pol, Renske I. Wadman, Camiel A. Wijngaarde, Bart Bartels, Louise Otto, Inge Cuppen, Leonard H. van den Berg, Ruben P. A. van Eijk, Leonard H. van den Berg and Fay‐Lynn Asselman and has published in prestigious journals such as PLoS ONE, Neurology and Clinical Neurophysiology.

In The Last Decade

Marloes Stam

25 papers receiving 830 citations

Peers

Marloes Stam
Inge Cuppen Netherlands
Renske I. Wadman Netherlands
Jessica O’Hagen United States
Kristin J. Krosschell United States
Louise Otto Netherlands
Amy Pasternak United States
Inge Cuppen Netherlands
Marloes Stam
Citations per year, relative to Marloes Stam Marloes Stam (= 1×) peers Inge Cuppen

Countries citing papers authored by Marloes Stam

Since Specialization
Citations

This map shows the geographic impact of Marloes Stam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marloes Stam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marloes Stam more than expected).

Fields of papers citing papers by Marloes Stam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marloes Stam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marloes Stam. The network helps show where Marloes Stam may publish in the future.

Co-authorship network of co-authors of Marloes Stam

This figure shows the co-authorship network connecting the top 25 collaborators of Marloes Stam. A scholar is included among the top collaborators of Marloes Stam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marloes Stam. Marloes Stam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stam, Marloes, Harold H G Tan, Ruben Schmidt, et al.. (2024). Brain magnetic resonance imaging of patients with spinal muscular atrophy type 2 and 3. NeuroImage Clinical. 44. 103708–103708. 1 indexed citations
2.
Wijngaarde, Camiel A., Fay‐Lynn Asselman, Marloes Stam, et al.. (2024). Natural History of Mandibular Function in Spinal Muscular Atrophy Types 2 and 3. Journal of Neuromuscular Diseases. 11(3). 655–664. 4 indexed citations
3.
Bartels, Bart, Jeroen A. L. Jeneson, Fay‐Lynn Asselman, et al.. (2023). Enhanced low-threshold motor unit capacity during endurance tasks in patients with spinal muscular atrophy using pyridostigmine. Clinical Neurophysiology. 154. 100–106. 5 indexed citations
4.
Veldhoen, Esther S., Camiel A. Wijngaarde, Ruben P. A. van Eijk, et al.. (2023). Lung function decline preceding chronic respiratory failure in spinal muscular atrophy: a national prospective cohort study. Orphanet Journal of Rare Diseases. 18(1). 40–40. 5 indexed citations
5.
Veldhoen, Esther S., Camiel A. Wijngaarde, Erik H.J. Hulzebos, et al.. (2022). Natural history of respiratory muscle strength in spinal muscular atrophy: a prospective national cohort study. Orphanet Journal of Rare Diseases. 17(1). 70–70. 19 indexed citations
6.
Stam, Marloes, Camiel A. Wijngaarde, Bart Bartels, et al.. (2022). Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2–4. Brain Communications. 5(1). fcac324–fcac324. 18 indexed citations
7.
Wijngaarde, Camiel A., Esther S. Veldhoen, Ruben P. A. van Eijk, et al.. (2020). Natural history of lung function in spinal muscular atrophy. Orphanet Journal of Rare Diseases. 15(1). 88–88. 63 indexed citations
8.
Bartels, Bart, Janke F. de Groot, Camiel A. Wijngaarde, et al.. (2020). Fatigability in spinal muscular atrophy: validity and reliability of endurance shuttle tests. Orphanet Journal of Rare Diseases. 15(1). 75–75. 30 indexed citations
9.
Otto, Louise, W. Ludo van der Pol, Lara Schlaffke, et al.. (2020). Quantitative MRI of skeletal muscle in a cross‐sectional cohort of patients with spinal muscular atrophy types 2 and 3. NMR in Biomedicine. 33(10). e4357–e4357. 41 indexed citations
10.
Wijngaarde, Camiel A., Marloes Stam, Louise Otto, et al.. (2020). Population-based analysis of survival in spinal muscular atrophy. Neurology. 94(15). e1634–e1644. 58 indexed citations
11.
Wadman, Renske I., Marc Jansen, Ewout J. N. Groen, et al.. (2020). Analysis of FUS , PFN2, TDP-43 , and PLS3 as potential disease severity modifiers in spinal muscular atrophy. Neurology Genetics. 6(1). e386–e386. 13 indexed citations
12.
Stam, Marloes, Martijn Froeling, M.E.P. Philippens, et al.. (2019). Magnetic resonance imaging of the cervical spinal cord in spinal muscular atrophy. NeuroImage Clinical. 24. 102002–102002. 10 indexed citations
13.
Bartels, Bart, Marloes Stam, Renske I. Wadman, et al.. (2019). Assessment of fatigability in patients with spinal muscular atrophy: development and content validity of a set of endurance tests. BMC Neurology. 19(1). 21–21. 37 indexed citations
14.
Stam, Marloes, Renske I. Wadman, Camiel A. Wijngaarde, et al.. (2018). Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2–4 (SPACE trial). BMJ Open. 8(7). e019932–e019932. 32 indexed citations
15.
Stam, Marloes, Renske I. Wadman, Bart Bartels, et al.. (2018). A continuous repetitive task to detect fatigability in spinal muscular atrophy. Orphanet Journal of Rare Diseases. 13(1). 160–160. 21 indexed citations
16.
Wijngaarde, Camiel A., A. Christian Blank, Marloes Stam, et al.. (2017). Cardiac pathology in spinal muscular atrophy: a systematic review. Orphanet Journal of Rare Diseases. 12(1). 67–67. 73 indexed citations
17.
Wadman, Renske I., Marloes Stam, Marc Jansen, et al.. (2016). A Comparative Study of SMN Protein and mRNA in Blood and Fibroblasts in Patients with Spinal Muscular Atrophy and Healthy Controls. PLoS ONE. 11(11). e0167087–e0167087. 36 indexed citations
18.
Vlam, Lotte, Marloes Stam, Wilco de Jager, et al.. (2015). Cytokine profiles in multifocal motor neuropathy and progressive muscular atrophy. Journal of Neuroimmunology. 286. 1–4. 5 indexed citations
19.
Vlam, Lotte, Sanne Piepers, Nadia A. Sutedja, et al.. (2014). Association of IgM monoclonal gammopathy with progressive muscular atrophy and multifocal motor neuropathy: a case–control study. Journal of Neurology. 262(3). 666–673. 17 indexed citations
20.
Geytenbeek, Johanna, Laurike Harlaar, Marloes Stam, et al.. (2010). Utility of language comprehension tests for unintelligible or non‐speaking children with cerebral palsy: a systematic review. Developmental Medicine & Child Neurology. 52(12). 1098–1098. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026